Delivery Order SPE2DB20D2104-SPE2DB23FR07N
- Not listed
- This federal contract award, valued at $2,310.41, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 36,000 units of a 100-count capsule product, CREON DR. The contract has a completion date of April 28, 2022 and uses a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,336.08 firm fixed-price delivery order covers the supply of 12,000 unit capsules of the pharmaceutical product CREON DR 100S. The contract has an ultimate completion date of April 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which specializes in pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order valued at $2,901.78 for the delivery of 24,000 units of the pharmaceutical product Creon DR 24,000 capsules. The contract is a firm fixed-price delivery order with a completion date of September 28, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,635.08, is a delivery order for the supply of 24,000 units of Creon DR 100 capsules. The contract has a completion date of September 28, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The company holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 24,000 unit capsules of the medication CREON DR. The $5,323.90 fixed-price contract has a completion date of May 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,542.73 firm fixed-price delivery order is for 24,000 units of the medication CREON DR 100S capsules. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 36,000 units of Creon DR 100s capsules. The $7,102.97 firm fixed-price contract has a completion date of January 25, 2023, and is an open competition award with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
- This federal contract award, valued at $13,247.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and runs through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract, valued at $15,821.94, is for the delivery of 24,000 units of the pharmaceutical product CREON DR 100S capsules. The contract is a firm fixed-price delivery order with a completion date of May 16, 2023. This award is not part of a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an award ceiling value of $9,450.58 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00. The contract is for the delivery of 36,000 unit capsules of the pharmaceutical product "CREON DR" in 100-count bottles. The contract has a firm-fixed price...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FR07NDelivery Order
This federal contract award, valued at $1,377.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 36,000 units of the drug CREON DR in 100-count capsule bottles, with a performance period ending on November 15, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was made through full and open competition, with no set-aside designation. It reflects Amerisourcebergen's capability to meet the diverse and critical pharmaceutical needs of the federal government on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/14/22 |